EP3370775
COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.11.2016EP published:
19.4.2023EP application number:
16805576.2
EPO information:
European Patent Register
Max expiry date:
2.11.2036
Title in English:
COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
3.11.2016EP application
19.4.2023EP Publication
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, South San Francisco, CA 94080, US
Name:
Board of Regents, The University of Texas SystemAddress:
201 West 7th Street, Austin, TX 78701, US
Inventor
Name:
MERCHANT, MarkAddress:
South San Francisco, California 94080, US
Name:
SAMPATH, DeepakAddress:
South San Francisco, California 94080, US
Name:
KONOPLEVA, Marina YurievnaAddress:
Houston, Texas 77030, US
Name:
HAN, LinaAddress:
Houston, Texas 77030, US
Priority
Number:
201562250231 PDate:
3.11.2015Country:
US
Number:
201562263082 PDate:
4.12.2015Country:
US
Classification
Categories:
A61K 31/4523, A61K 31/496, A61P 35/00, A61P 35/02